Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin

doi:10.4254/wjh.v9.i3.161

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7345)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

386

WORD

224

HTML

3185

Figures (1-4)

307

Sum=4102

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1240

Download

2003

Sum=3243

Jan 28, 2017 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Jan 28, 2017; 9(3): 161-166
Published online Jan 28, 2017. doi: 10.4254/wjh.v9.i3.161

Full Size Figure Download Figure

Figure 4 Course of haemoglobin, leucocytes and viral load during and after antiviral treatment. Attendance to the emergency unit, tuberculosis diagnosis and start of therapy are shown according to time. TB: Tuberculosis.

Citation: Ballester-Ferré MP, Martínez F, Garcia-Gimeno N, Mora F, Serra MA. Miliary tuberculosis infection during hepatitis C treatment with sofosbuvir and ledipasvir plus ribavirin. World J Hepatol 2017; 9(3): 161-166
URL: https://www.wjgnet.com/1948-5182/full/v9/i3/161.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i3.161